Jci_page_head_homepage_01 Jci_page_head_homepage_02
Kip A. West, John Brognard, Amy S. Clark, Ilona R. Linnoila, Xiaowei Yang, Sandra M. Swain, Curtis Harris, Steven Belinsky, Phillip A. Dennis
Published in Volume 111, Issue 1
J Clin Invest. 2003; 111(1):81–90 doi:10.1172/JCI16147
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 3

Effect of nAchR antagonists on nicotinic activation of Akt in NHBEs and SAECs. (a) Nicotine. Only LY294002 or the α34 antagonist DHβE inhibited nicotine-induced Akt phosphorylation in NHBEs (upper left panels) and SAECs (lower panels). To confirm the role of α3 nAchRs in activating Akt in NHBEs, α-ATX (an α3 agonist) was added to NHBEs with or without DHβE (upper right panels). (b) NNK. In contrast to nicotine-mediated Akt phosphorylation, NNK-induced phosphorylation in NHBEs was inhibited by LY294002, the α7 antagonists α-BTX and MLA, and the nonspecific inhibitor MCA. DHβE was ineffective.